期刊文献+

催产素受体配体及其中枢和外周功能研究进展 被引量:10

Research progress of oxytocin receptor ligands and its role in central nerve system and peripheral organs
下载PDF
导出
摘要 催产素(oxytocin,OT)是一个含有9个氨基酸残基的环状神经肽,除了传统的缩宫和泌乳作用外,近年来,OT在中枢神经系统及其它外周器官的新功能也受到广泛关注,如改善精神分裂症、自闭症和焦虑症等精神心理症状。OT通过与其受体(oxytocin receptor,OTR)结合而发挥生理作用,目前研究人员以OT信号系统作为药物靶标,通过开发新型OTR配体(即激动剂和拮抗剂)来预防和改善相应症状。该文从OTR药理学角度对其激动剂和拮抗剂及其生物学功能的最新研究进展进行了综述。 Oxytocin ( OT ) is a cyclic neuropeptide containing nine amino acids residues, in addition to the traditional roles of uterine contraction and lactation, it also plays important roles in the central nervous system and other peripheral organs, such as improving schizophrenia, autism - related psychiatric and psychological symptoms. Oxytocin exhibits its physiological functions by binding to its receptor (oxytocin receptor,OTR). Currently researchers are manipulating OT system by developing new OTR ligand ( agonists and antagonists ) , hoping to prevent and treat OTR related diseases. This paper reviews the latest devel-opment of OTR agonists, antagonists and its physiological roles in central nerve system and peripheral organs.
出处 《中国药理学通报》 CAS CSCD 北大核心 2014年第6期752-756,共5页 Chinese Pharmacological Bulletin
基金 云南省高端科技人才基金(No 2012HA008) 云南省人培基金资助(No KKSY201226129)
关键词 催产素 催产素受体 配体 激动剂 拮抗剂 中枢神经系统 外周器官 oxytocin oxytocin receptor ligands agonists antagonists central nerve system peripheral organs
  • 相关文献

参考文献23

  • 1Rahman Z, Resnick L, Rosenzweig-Lipson S, Ring R. Methods of treatment using oxytocin receptor agonists[P]. Pat, US20070117794A1, 2007-5-24.
  • 2Petty M A, Lang R E, Unger T, Ganten D . The cardiovascular effects of oxytocin in conscious male rats[J]. Eur J Pharmacol, 1985, 112(2): 203-10.
  • 3Dyer R A, Butwick A J, Carvalho B. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist[J]. Curr Opin Anaesthesiol, 2011, 24(3): 255-61.
  • 4Mezzacappa E S, Katlin E S. Breast-feeding is associated with reduced perceived stress and negative mood in mothers[J]. Health Psychol, 2002, 21(2): 187-93.
  • 5Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation[J]. Physiol Rev, 2001, 81(2): 629-83.
  • 6Schwarz M, Page P, Pomel V, et al. Pyrrolidine oxadiazole- and thiadlazole oxime derivatixes being oxytocin receptor antagonists[P]. Pat WO2002102799A2: Applied Research Systems ARS Holding, 2002-10-27.
  • 7Schwarz M Q, Quattropani A, Page P, et al. Pyrrolidine oxadiazole-and thiadlazole derivatixes[P]. Pat. US20040220238A1: Applied Research Systems ARS Holding, 2004-11-4.
  • 8Kovacs G L, Sarnyai Z, Szabo G. Oxytocin and addiction: a review[J]. Psychoneuroendocrinology, 1998, 23(8): 945-62.
  • 9Carson D S, Guastella A J, Taylor E R, et al. A brief history of oxytocin and its role in modulating psychostimulant effects[J]. J Psychopharmacol, 2013, 27(3): 231-47.
  • 10Huang C, Syed F, Li L, et al. Oxytocin receptor agonists and their use for the treatment of pulmonary related diseases[P]. Pat US, 2010/0260675 A1, 2010-10-14.

二级参考文献5

共引文献65

同被引文献77

引证文献10

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部